Meanwhile, the results of in vivo assays also confirmed that transfection of MBNL1-AS1 or si-MBNL1-AS1 did not revert the tumorigenic abilities after ZFP36 knockdown in orthotopic breast cancer mice models (Figure 5(d)). This evidence concerns the gene MBNL1 and breast carcinoma.